United States Food and Drug Administration (USFDA) has conducted an inspection at Jeevan Scientific Technology’s (JSTL) Bioanalytical Facility, at Manikonda, Hyderabad. The purpose of the inspection was to review the BA/BE studies as well as the operations, systems and procedures. The inspector started the review on February 20, 2024 and closed on February 23, 2024.
The inspector closed the inspection with no 483, i.e., no findings. The inspector concluded that the entire JSTL team is well trained, knowledgeable and experienced with International Regulatory requirements and Good practices, working within an adequately designed infrastructure and that the organization is compliant with all applicable regulations.
Jeevan Scientific Technology carries business clinical research and data management services.
| Company Name | CMP |
|---|---|
| TCS | 2581.65 |
| Infosys | 1318.60 |
| HCL Tech. | 1442.50 |
| Wipro | 204.35 |
| Tech Mahindra | 1511.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: